$GNMK Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GenMark Diagnostics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in GenMark Diagnostics, Inc.. Get notifications about new insider transactions in GenMark Diagnostics, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 06 2012 | GNMK | GenMark Diagnostic ... | Hawkins Jeffrey Alan | SVP, Marketing & Bu ... | Payment of Exercise | F | 8.64 | 66 | 570 | 84,701 | 84.8 K to 84.7 K (-0.08 %) |
| Oct 05 2012 | GNMK | GenMark Diagnostic ... | Hawkins Jeffrey Alan | SVP, Marketing & Bu ... | Payment of Exercise | F | 8.50 | 65 | 553 | 84,767 | 84.8 K to 84.8 K (-0.08 %) |
| Sep 06 2012 | GNMK | GenMark Diagnostic ... | Hawkins Jeffrey Alan | SVP, Marketing & Bu ... | Payment of Exercise | F | 7.53 | 66 | 497 | 84,832 | 84.9 K to 84.8 K (-0.08 %) |
| Jul 06 2012 | GNMK | GenMark Diagnostic ... | Hawkins Jeffrey Alan | SVP, Marketing & Bu ... | Payment of Exercise | F | 4.65 | 66 | 307 | 84,898 | 85 K to 84.9 K (-0.08 %) |
| Jun 28 2012 | GNMK | GenMark Diagnostic ... | OBOYLE KEVIN C | Director | Buy | P | 4.20 | 11,905 | 50,001 | 24,545 | 12.6 K to 24.5 K (+94.19 %) |
| Jun 28 2012 | GNMK | GenMark Diagnostic ... | Kayyem Jon Faiz | Chief Scientific Of ... | Buy | P | 4.20 | 50,000 | 210,000 | 144,960 | 95 K to 145 K (+52.65 %) |
| Jun 28 2012 | GNMK | GenMark Diagnostic ... | Garces Jorge | SVP, Research & Dev ... | Buy | P | 4.20 | 5,000 | 21,000 | 5,000 | 0 to 5 K |
| Jun 28 2012 | GNMK | GenMark Diagnostic ... | MASSARANY HANY | President and CEO | Buy | P | 4.20 | 25,000 | 105,000 | 427,456 | 402.5 K to 427.5 K (+6.21 %) |
| Jun 28 2012 | GNMK | GenMark Diagnostic ... | SLANSKY RICHARD B | Chief Financial Off ... | Buy | P | 4.20 | 25,000 | 105,000 | 55,395 | 30.4 K to 55.4 K (+82.25 %) |
| Jun 28 2012 | GNMK | GenMark Diagnostic ... | FAULKNER DARYL | Director | Buy | P | 4.20 | 5,000 | 21,000 | 31,778 | 26.8 K to 31.8 K (+18.67 %) |
| Jun 28 2012 | GNMK | GenMark Diagnostic ... | Fox James | Director | Buy | P | 4.20 | 23,810 | 100,002 | 23,810 | 0 to 23.8 K |
| Jun 28 2012 | GNMK | GenMark Diagnostic ... | GLEESON CHRISTOPHER M | Director | Buy | P | 4.20 | 60,000 | 252,000 | 232,414 | 172.4 K to 232.4 K (+34.80 %) |
| Jun 08 2012 | GNMK | GenMark Diagnostic ... | Fox James | Director | Grant | A | 0.00 | 10,112 | 0 | 62,066 | 52 K to 62.1 K (+19.46 %) |
| Jun 15 2012 | GNMK | GenMark Diagnostic ... | WORLAND STEPHEN T | Director | Option Exercise | A | 4.34 | 25,000 | 108,500 | 25,000 | |
| Jun 08 2012 | GNMK | GenMark Diagnostic ... | FAULKNER DARYL | Director | Grant | A | 0.00 | 10,112 | 0 | 26,778 | 16.7 K to 26.8 K (+60.67 %) |
| Jun 08 2012 | GNMK | GenMark Diagnostic ... | GLEESON CHRISTOPHER M | Director | Grant | A | 0.00 | 16,854 | 0 | 172,414 | 155.6 K to 172.4 K (+10.83 %) |
| Jun 08 2012 | GNMK | GenMark Diagnostic ... | OBOYLE KEVIN C | Director | Grant | A | 0.00 | 12,640 | 0 | 12,640 | 0 to 12.6 K |
| Jun 05 2012 | GNMK | GenMark Diagnostic ... | Hawkins Jeffrey Alan | SVP, Marketing & Bu ... | Payment of Exercise | F | 4.37 | 65 | 284 | 84,964 | 85 K to 85 K (-0.08 %) |
| Jun 05 2012 | GNMK | GenMark Diagnostic ... | Hawkins Jeffrey Alan | SVP, Marketing & Bu ... | Payment of Exercise | F | 4.37 | 463 | 2,023 | 85,029 | 85.5 K to 85 K (-0.54 %) |
| May 31 2012 | GNMK | GenMark Diagnostic ... | SLANSKY RICHARD B | Chief Financial Off ... | Grant | A | 0.00 | 30,395 | 0 | 30,395 | 0 to 30.4 K |
| May 08 2012 | GNMK | GenMark Diagnostic ... | SLANSKY RICHARD B | Chief Financial Off ... | Option Exercise | A | 4.73 | 76,849 | 363,496 | 76,849 | |
| May 04 2012 | GNMK | GenMark Diagnostic ... | Hawkins Jeffrey Alan | SVP, Marketing & Bu ... | Payment of Exercise | F | 4.70 | 66 | 310 | 85,492 | 85.6 K to 85.5 K (-0.08 %) |
| Apr 04 2012 | GNMK | GenMark Diagnostic ... | Hawkins Jeffrey Alan | SVP, Marketing & Bu ... | Payment of Exercise | F | 4.15 | 66 | 274 | 85,558 | 85.6 K to 85.6 K (-0.08 %) |
| Apr 06 2012 | GNMK | GenMark Diagnostic ... | Ross Paul | CFO | Payment of Exercise | F | 0.00 | 2,788 | 0 | 60,953 | 63.7 K to 61 K (-4.37 %) |
| Mar 07 2012 | GNMK | GenMark Diagnostic ... | Hawkins Jeffrey Alan | SVP, Marketing & Bu ... | Payment of Exercise | F | 4.15 | 76 | 315 | 85,624 | 85.7 K to 85.6 K (-0.09 %) |
| Mar 02 2012 | GNMK | GenMark Diagnostic ... | Williams Jennifer Anne | SVP Global Operatio ... | Grant | A | 0.00 | 74,063 | 0 | 219,269 | 145.2 K to 219.3 K (+51.01 %) |
| Mar 02 2012 | GNMK | GenMark Diagnostic ... | Ross Paul | CFO & Secretary | Grant | A | 0.00 | 30,000 | 0 | 63,741 | 33.7 K to 63.7 K (+88.91 %) |
| Mar 02 2012 | GNMK | GenMark Diagnostic ... | Kayyem Jon Faiz | Chief Scientific Of ... | Grant | A | 0.00 | 64,375 | 0 | 94,960 | 30.6 K to 95 K (+210.48 %) |
| Mar 02 2012 | GNMK | GenMark Diagnostic ... | Hawkins Jeffrey Alan | SVP, Marketing & Bu ... | Payment of Exercise | F | 4.11 | 2,142 | 8,804 | 85,700 | 87.8 K to 85.7 K (-2.44 %) |
| Mar 02 2012 | GNMK | GenMark Diagnostic ... | Hawkins Jeffrey Alan | SVP, Marketing & Bu ... | Grant | A | 0.00 | 53,125 | 0 | 87,842 | 34.7 K to 87.8 K (+153.02 %) |
| Mar 02 2012 | GNMK | GenMark Diagnostic ... | Cohen Matthew Robert | SVP, Gen Counsel & ... | Grant | A | 0.00 | 5,000 | 0 | 31,856 | 26.9 K to 31.9 K (+18.62 %) |
| Mar 02 2012 | GNMK | GenMark Diagnostic ... | MASSARANY HANY | President and CEO | Grant | A | 0.00 | 141,207 | 0 | 402,456 | 261.2 K to 402.5 K (+54.05 %) |
| Feb 07 2012 | GNMK | GenMark Diagnostic ... | Williams Jennifer Anne | SVP Global Operatio ... | Payment of Exercise | F | 4.51 | 156 | 703 | 145,206 | 145.4 K to 145.2 K (-0.11 %) |
| Feb 07 2012 | GNMK | GenMark Diagnostic ... | Hawkins Jeffrey Alan | SVP, Marketing & Bu ... | Payment of Exercise | F | 4.51 | 76 | 343 | 34,717 | 34.8 K to 34.7 K (-0.22 %) |
| Jan 19 2012 | GNMK | GenMark Diagnostic ... | Williams Jennifer Anne | SVP Global Operatio ... | Payment of Exercise | F | 4.38 | 156 | 683 | 145,362 | 145.5 K to 145.4 K (-0.11 %) |
| Jan 19 2012 | GNMK | GenMark Diagnostic ... | Hawkins Jeffrey Alan | SVP, Marketing & Bu ... | Payment of Exercise | F | 4.38 | 76 | 333 | 34,793 | 34.9 K to 34.8 K (-0.22 %) |
| Jan 05 2012 | GNMK | GenMark Diagnostic ... | Calvin Bradley | Senior VP, Global M ... | Option Exercise | A | 4.38 | 32,500 | 142,350 | 32,500 | |
| Jan 05 2012 | GNMK | GenMark Diagnostic ... | Calvin Bradley | Senior VP, Global M ... | Grant | A | 4.38 | 20,537 | 89,952 | 20,537 | 0 to 20.5 K |
| Jan 05 2012 | GNMK | GenMark Diagnostic ... | Cohen Matthew Robert | SVP, Gen Counsel & ... | Option Exercise | A | 4.38 | 42,500 | 186,150 | 42,500 | |
| Jan 05 2012 | GNMK | GenMark Diagnostic ... | Cohen Matthew Robert | SVP, Gen Counsel & ... | Grant | A | 4.38 | 26,856 | 117,629 | 26,856 | 0 to 26.9 K |
| Jan 05 2012 | GNMK | GenMark Diagnostic ... | GLEESON CHRISTOPHER M | Director | Option Exercise | A | 4.38 | 17,900 | 78,402 | 17,900 | |
| Jan 05 2012 | GNMK | GenMark Diagnostic ... | OBOYLE KEVIN C | Director | Option Exercise | A | 4.38 | 13,426 | 58,806 | 13,426 | |
| Jan 05 2012 | GNMK | GenMark Diagnostic ... | FAULKNER DARYL | Director | Option Exercise | A | 4.38 | 10,741 | 47,046 | 10,741 | |
| Dec 13 2011 | GNMK | GenMark Diagnostic ... | Hawkins Jeffrey Alan | SVP, Marketing & Bu ... | Payment of Exercise | F | 4.54 | 63 | 286 | 34,869 | 34.9 K to 34.9 K (-0.18 %) |
| Dec 12 2011 | GNMK | GenMark Diagnostic ... | Williams Jennifer Anne | SVP Global Operatio ... | Buy | P | 4.15 | 2,500 | 10,375 | 145,518 | 143 K to 145.5 K (+1.75 %) |
| Nov 22 2011 | GNMK | GenMark Diagnostic ... | Hawkins Jeffrey Alan | SVP, Marketing & Bu ... | Payment of Exercise | F | 5.04 | 2,361 | 11,899 | 34,932 | 37.3 K to 34.9 K (-6.33 %) |
| Nov 22 2011 | GNMK | GenMark Diagnostic ... | Hawkins Jeffrey Alan | SVP, Marketing & Bu ... | Payment of Exercise | F | 5.72 | 3,089 | 17,669 | 37,293 | 40.4 K to 37.3 K (-7.65 %) |
| Apr 07 2011 | GNMK | GenMark Diagnostic ... | Kayyem Jon Faiz | Chief Scientific Of ... | Grant | A | 0.00 | 19,585 | 0 | 30,585 | 11 K to 30.6 K (+178.05 %) |
| Jun 23 2011 | GNMK | GenMark Diagnostic ... | Kayyem Jon Faiz | Chief Scientific Of ... | Buy | P | 4.25 | 100,000 | 425,000 | 669,308 | 569.3 K to 669.3 K (+17.57 %) |
| Apr 07 2011 | GNMK | GenMark Diagnostic ... | Hawkins Jeffrey Alan | SVP, Marketing & Bu ... | Grant | A | 0.00 | 8,538 | 0 | 40,382 | 31.8 K to 40.4 K (+26.81 %) |
| Apr 07 2011 | GNMK | GenMark Diagnostic ... | Williams Jennifer Anne | SVP Global Operatio ... | Grant | A | 0.00 | 10,785 | 0 | 143,018 | 132.2 K to 143 K (+8.16 %) |
| Apr 07 2011 | GNMK | GenMark Diagnostic ... | Ross Paul | CFO & Secretary | Option Exercise | A | 3.95 | 52,500 | 207,375 | 52,500 | |
| Apr 07 2011 | GNMK | GenMark Diagnostic ... | Ross Paul | CFO & Secretary | Grant | A | 0.00 | 33,741 | 0 | 33,741 | 0 to 33.7 K |
| Mar 24 2011 | GNMK | GenMark Diagnostic ... | Singhal Pankaj | Sr. VP, Product Dev ... | Grant | A | 0.00 | 4,000 | 0 | 4,000 | 0 to 4 K |
| Mar 18 2011 | GNMK | GenMark Diagnostic ... | Williams Jennifer Anne | SVP Global Operatio ... | Buy | P | 3.90 | 5,500 | 21,450 | 132,233 | 126.7 K to 132.2 K (+4.34 %) |
| Mar 18 2011 | GNMK | GenMark Diagnostic ... | GLEESON CHRISTOPHER M | Interim CEO | Buy | P | 4.00 | 15,000 | 60,000 | 155,560 | 140.6 K to 155.6 K (+10.67 %) |
| Mar 03 2011 | GNMK | GenMark Diagnostic ... | Williams Jennifer Anne | SVP Global Operatio ... | Grant | A | 0.00 | 23,900 | 0 | 126,733 | 102.8 K to 126.7 K (+23.24 %) |
| Mar 03 2011 | GNMK | GenMark Diagnostic ... | Kayyem Jon Faiz | Chief Scientific Of ... | Grant | A | 0.00 | 11,000 | 0 | 11,000 | 0 to 11 K |
| Mar 03 2011 | GNMK | GenMark Diagnostic ... | Hawkins Jeffrey Alan | SVP, Marketing & Bu ... | Grant | A | 0.00 | 22,400 | 0 | 31,844 | 9.4 K to 31.8 K (+237.19 %) |
| Nov 05 2010 | GNMK | GenMark Diagnostic ... | Williams Jennifer Anne | SVP Global Operatio ... | Grant | A | 4.34 | 19,500 | 84,630 | 102,833 | 83.3 K to 102.8 K (+23.40 %) |
| Nov 05 2010 | GNMK | GenMark Diagnostic ... | Hawkins Jeffrey Alan | SVP, Marketing & Bu ... | Grant | A | 4.34 | 9,444 | 40,987 | 9,444 | 0 to 9.4 K |
| Sep 08 2010 | GNMK | GenMark Diagnostic ... | Kemper Steven J | CFO, Treasurer & Se ... | Buy | P | 4.19 | 2,600 | 10,894 | 5,000 | 2.4 K to 5 K (+108.33 %) |
| Sep 08 2010 | GNMK | GenMark Diagnostic ... | Kemper Steven J | CFO, Treasurer & Se ... | Buy | P | 4.18 | 500 | 2,090 | 2,400 | 1.9 K to 2.4 K (+26.32 %) |
| Sep 08 2010 | GNMK | GenMark Diagnostic ... | Kemper Steven J | CFO, Treasurer & Se ... | Buy | P | 4.00 | 1,900 | 7,600 | 1,900 | 0 to 1.9 K |
| Sep 03 2010 | GNMK | GenMark Diagnostic ... | Fox James | Director | Grant | A | 0.00 | 10,922 | 0 | 51,954 | 41 K to 52 K (+26.62 %) |
| Sep 03 2010 | GNMK | GenMark Diagnostic ... | Fox James | Director | Grant | A | 0.00 | 41,032 | 0 | 41,032 | 0 to 41 K |
| Aug 12 2010 | GNMK | GenMark Diagnostic ... | GLEESON CHRISTOPHER M | Interim CEO | Grant | A | 0.00 | 109,375 | 0 | 140,560 | 31.2 K to 140.6 K (+350.73 %) |
| Jun 07 2010 | GNMK | GenMark Diagnostic ... | FAULKNER DARYL | Director | Option Exercise | J | 6.49 | 5,785 | 37,545 | 5,785 | |
| Jun 07 2010 | GNMK | GenMark Diagnostic ... | FAULKNER DARYL | Director | Option Exercise | J | 6.93 | 25,080 | 173,804 | 25,080 | |
| Jun 07 2010 | GNMK | GenMark Diagnostic ... | FAULKNER DARYL | Director | Buy | P | 6.00 | 16,666 | 99,996 | 16,666 | 0 to 16.7 K |
| Jun 07 2010 | GNMK | GenMark Diagnostic ... | Kayyem Jon Faiz | President & CEO | Option Exercise | J | 6.49 | 248,568 | 1,613,206 | 248,568 | |
| Jun 07 2010 | GNMK | GenMark Diagnostic ... | Kayyem Jon Faiz | President & CEO | Buy | P | 6.00 | 250,000 | 1,500,000 | 569,308 | 319.3 K to 569.3 K (+78.29 %) |
| Jun 07 2010 | GNMK | GenMark Diagnostic ... | Kayyem Jon Faiz | President & CEO | Buy | J | 0.00 | 319,308 | 0 | 319,308 | 0 to 319.3 K |
| Jun 07 2010 | GNMK | GenMark Diagnostic ... | Kayyem Jon Faiz | President & CEO | Buy | J | 0.00 | 124,934 | 0 | 124,934 | 0 to 124.9 K |
| Jun 07 2010 | GNMK | GenMark Diagnostic ... | Kayyem Jon Faiz | President & CEO | Buy | J | 0.00 | 61,651 | 0 | 61,651 | 0 to 61.7 K |
| Jun 07 2010 | GNMK | GenMark Diagnostic ... | Kemper Steven J | CFO, Treasurer & Se ... | Option Exercise | J | 6.49 | 85,224 | 553,104 | 85,224 | |
| Jun 07 2010 | GNMK | GenMark Diagnostic ... | Bellano John | SR. VP, Commercial ... | Option Exercise | J | 6.49 | 85,224 | 553,104 | 85,224 | |
| Jun 07 2010 | GNMK | GenMark Diagnostic ... | Bellano John | SR. VP, Commercial ... | Buy | P | 6.00 | 8,333 | 49,998 | 8,333 | 0 to 8.3 K |
| Jun 07 2010 | GNMK | GenMark Diagnostic ... | Singhal Pankaj | Sr. VP, Product Dev ... | Option Exercise | J | 6.49 | 85,224 | 553,104 | 85,224 | |
| Jun 07 2010 | GNMK | GenMark Diagnostic ... | GLEESON CHRISTOPHER M | Director | Option Exercise | J | 9.98 | 88,317 | 881,404 | 88,317 | |
| Jun 07 2010 | GNMK | GenMark Diagnostic ... | GLEESON CHRISTOPHER M | Director | Option Exercise | J | 6.49 | 4,821 | 31,288 | 4,821 | |
| Jun 07 2010 | GNMK | GenMark Diagnostic ... | GLEESON CHRISTOPHER M | Director | Option Exercise | J | 6.49 | 25,080 | 162,769 | 25,080 | |
| Jun 07 2010 | GNMK | GenMark Diagnostic ... | GLEESON CHRISTOPHER M | Director | Option Exercise | J | 6.93 | 25,080 | 173,804 | 25,080 | |
| Jun 07 2010 | GNMK | GenMark Diagnostic ... | GLEESON CHRISTOPHER M | Director | Buy | P | 6.00 | 1,333,333 | 7,999,998 | 1,562,565 | 229.2 K to 1.6 M (+581.65 %) |
| Jun 07 2010 | GNMK | GenMark Diagnostic ... | GLEESON CHRISTOPHER M | Director | Buy | J | 0.00 | 229,232 | 0 | 229,232 | 0 to 229.2 K |
| Jun 07 2010 | GNMK | GenMark Diagnostic ... | GLEESON CHRISTOPHER M | Director | Buy | J | 0.00 | 31,185 | 0 | 31,185 | 0 to 31.2 K |
| Jun 02 2010 | GNMK | GenMark Diagnostic ... | GLEESON CHRISTOPHER M | Director | Option Exercise | A | 6.00 | 24,050 | 144,300 | 24,050 | |
| Jun 02 2010 | GNMK | GenMark Diagnostic ... | OBOYLE KEVIN C | Director | Option Exercise | A | 6.00 | 18,050 | 108,300 | 18,050 | |
| Jun 02 2010 | GNMK | GenMark Diagnostic ... | OBOYLE KEVIN C | Director | Option Exercise | A | 6.00 | 25,000 | 150,000 | 25,000 | |
| Jun 02 2010 | GNMK | GenMark Diagnostic ... | FAULKNER DARYL | Director | Option Exercise | A | 6.00 | 14,450 | 86,700 | 14,450 | |
| Jun 02 2010 | GNMK | GenMark Diagnostic ... | Kemper Steven J | CFO, Treasurer & Se ... | Option Exercise | A | 6.00 | 21,300 | 127,800 | 21,300 |